Skip to content

diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)

diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02980978
Acronym
ENHANCED
Enrollment
118
Registered
2016-12-02
Start date
2016-04-30
Completion date
2018-11-13
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

This study aims to randomly assign individuals with type 2 diabetes into the ENHANCED randomized control trial. The study is being conducted by the Minneapolis Heart Institute Foundation (MHIF) and will have two study sites 1) Hutchinson Health and 2) New Ulm Medical Center. The study is primarily funded through the Academy of Nutrition and Dietetics (AND). The study will examine the impact of a registered dietitian-led, primary care integrated, telemedicine program on diabetes care measures (the 'D5') over one year as compared to usual care. The D5 goals include: blood pressure \<140/90 mmHg, taking a statin as appropriate, A1c \<8%, not using tobacco and taking an aspirin as appropriate.

Detailed description

Individuals will be invited to attend a baseline visit where they will have lab work done, anthropometrics (height, weight, waist circumference) and complete a lifestyle assessment. They will formally consent to participation by signing a study consent form. The same measures will be collected after completion of the one year study. Study participants will receive two sessions of free lab work, a diabetes education book, and brief coaching with a registered dietitian/certified diabetes educator. In addition, those randomized to the phone coaching will have access to a registered dietitian/certified diabetes educator on a monthly basis for one year of personalized health coaching for free. The intent of this coaching is to help individuals achieve diabetes optimal care or meeting all 5 Diabetes Care measures (blood glucose, blood pressure, tobacco use, statin and aspirin use). This program is designed to complement usual clinic-based primary care, with coaches documenting lab, biometrics and medication adjustments in the EHR, along with documenting phone encounters and communicating directly with patients' PCPs as needed. Documentation in the EHR uses an order created specifically for the study indicating the patient's research status. Lab work required as part of this research study at baseline and 12 months is covered by the study. Any lab work and/or medication co-pays or fees outside of the baseline and 12 month study visits are the responsibility of the patient and/or their insurance

Interventions

BEHAVIORALCoaching

Focus on nutrition, activity and appropriate medication use and adherence

Sponsors

Academy of Nutrition and Dietetics
CollaboratorOTHER
Minneapolis Heart Institute Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Diagnosis of Type 2 Diabetes 2. Individuals who are not meeting 3 or more D5 goals, 3. Have had a visit with a provider within the last 2 years

Exclusion criteria

1. Type 1 Diabetes 2. Chronic kidney disease (GFR \<30) 3. HIV 4. Institutional residence 5. Major cognitive or language barrier (as determined by program enrollment staff) 6. Other active end-stage disease (e.g., late stage cancer or pulmonary disease) 7. Actively receiving cancer treatment 8. Pregnant

Design outcomes

Primary

MeasureTime frameDescription
A1c (Laboratory Assessment)1 yearThe count of participants represents the number of individuals meeting A1c less than 8% at follow up

Other

MeasureTime frameDescription
Blood Pressure (Calibrated Cuff Measurement- Average of 3 Readings)1 yearThe count of participants represents the number of individuals meeting blood pressure less than 140/90 at follow up
Tobacco Use (Self-reported Questionnaire)1 yearThe count of participants represents those not using tobacco at follow up
Statin Use (as Noted in EMR)1 yearThe count of participants represents those taking a statin as indicated at follow up
Aspirin Use (as Noted in EMR)1 yearThe count of participants represents taking aspirin as indicated at follow up

Participant flow

Participants by arm

ArmCount
Intervention
Individuals assigned to the intervention group will have supplemental care provided by a registered dietitian/certified diabetes educator which includes counseling on lifestyle to improve diabetes and overall health. Additionally, individuals in this group may be started on medications (or adjustments to current medications) for blood pressure, cholesterol or blood glucose to meet diabetes care goals Coaching: Focus on nutrition, activity and appropriate medication use and adherence
60
Standard of Care
Individuals will be followed by their Primary Care Provider as standard of care and per usual clinical need
58
Total118

Baseline characteristics

CharacteristicStandard of CareTotalIntervention
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants20 Participants12 Participants
Age, Categorical
Between 18 and 65 years
50 Participants98 Participants48 Participants
Age, Continuous60.0 Years
STANDARD_DEVIATION 8.66
59.9 Years
STANDARD_DEVIATION 9.43
59.8 Years
STANDARD_DEVIATION 10.2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
3 Participants3 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants3 Participants1 Participants
Race (NIH/OMB)
White
52 Participants108 Participants56 Participants
Region of Enrollment
United States
58 participants118 participants60 participants
Sex: Female, Male
Female
25 Participants53 Participants28 Participants
Sex: Female, Male
Male
33 Participants65 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 600 / 58
other
Total, other adverse events
0 / 600 / 58
serious
Total, serious adverse events
0 / 600 / 58

Outcome results

Primary

A1c (Laboratory Assessment)

The count of participants represents the number of individuals meeting A1c less than 8% at follow up

Time frame: 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionA1c (Laboratory Assessment)35 Participants
Standard of CareA1c (Laboratory Assessment)35 Participants
Other Pre-specified

Aspirin Use (as Noted in EMR)

The count of participants represents taking aspirin as indicated at follow up

Time frame: 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionAspirin Use (as Noted in EMR)45 Participants
Standard of CareAspirin Use (as Noted in EMR)34 Participants
Other Pre-specified

Blood Pressure (Calibrated Cuff Measurement- Average of 3 Readings)

The count of participants represents the number of individuals meeting blood pressure less than 140/90 at follow up

Time frame: 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionBlood Pressure (Calibrated Cuff Measurement- Average of 3 Readings)24 Participants
Standard of CareBlood Pressure (Calibrated Cuff Measurement- Average of 3 Readings)20 Participants
Other Pre-specified

Statin Use (as Noted in EMR)

The count of participants represents those taking a statin as indicated at follow up

Time frame: 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionStatin Use (as Noted in EMR)50 Participants
Standard of CareStatin Use (as Noted in EMR)32 Participants
Other Pre-specified

Tobacco Use (Self-reported Questionnaire)

The count of participants represents those not using tobacco at follow up

Time frame: 1 year

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionTobacco Use (Self-reported Questionnaire)44 Participants
Standard of CareTobacco Use (Self-reported Questionnaire)40 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026